Professor, Pathology - (Research Scholar Track), Research Professor, BIO5 Institute
The personalized diagnosis, prognosis and treatment of cancer.
Professor, BIO5 Institute, Professor, Immunobiology, Professor, Medicine, Professor, Pathology, Professor, Pediatrics, Program Director, Blood and Bone Marrow Transplant, Professor, Cancer Biology - GIDP
Augmenting immune responses to cancer. Reducing relapse and graft versus host disease after hematopoietic cell transplantation.
Chair, Cancer Biology - GIDP, Co-Program Leader, Cancer Biology Research Program, Member of the Graduate Faculty, Professor, BIO5 Institute, Professor, Cellular and Molecular Medicine
Associate Professor, Applied BioSciences - GIDP, Associate Professor, BIO5 Institute, Associate Professor, Pathology - (Research Scholar Track)
We are studying how tumor cells escape immunosurveillance, a hallmark of cancer, in aggressive lymphomas. MHCII is a protein important for immunosurveillance. We are studying the underlying mechanisms of altered regulation of MHCII in lymphoma cells and its effects on tumor immunosurveillance.